Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 423

    1.

    In vitro Growth Inhibitory Activity and Malaria Risk in a Cohort Study in Mali.

    Crompton PD, Miura K, Traore B, Kayentao K, Ongoiba A, Weiss G, Doumbo S, Doumtabe D, Kone Y, Huang CY, Doumbo OK, Miller LH, Long CA, Pierce SK.

    Infect Immun. 2009 Nov 16. [Epub ahead of print]PMID: 19917712 [PubMed - as supplied by publisher]Related articles

    2.

    Perspective on malaria eradication: is eradication possible without modifying the mosquito?

    Miller LH, Pierce SK.

    J Infect Dis. 2009 Dec 1;200(11):1644-5. No abstract available. PMID: 19877845 [PubMed - in process]Related articles

    3.

    A randomized and controlled Phase 1 study of the safety and immunogenicity of the AMA1-C1/Alhydrogel((R))+CPG 7909 vaccine for Plasmodium falciparum malaria in semi-immune Malian adults.

    Sagara I, Ellis RD, Dicko A, Niambele MB, Kamate B, Guindo O, Sissoko MS, Fay MP, Guindo MA, Kante O, Saye R, Miura K, Long C, Mullen GE, Pierce M, Martin LB, Rausch K, Dolo A, Diallo DA, Miller LH, Doumbo OK.

    Vaccine. 2009 Oct 27. [Epub ahead of print]PMID: 19874925 [PubMed - as supplied by publisher]Related articles

    4.

    The TLR9 agonist CpG fails to enhance the acquisition of Plasmodium falciparum-specific memory B cells in semi-immune adults in Mali.

    Traore B, Koné Y, Doumbo S, Doumtabé D, Traoré A, Crompton PD, Mircetic M, Huang CY, Kayentao K, Dicko A, Sagara I, Ellis RD, Miura K, Guindo A, Miller LH, Doumbo OK, Pierce SK.

    Vaccine. 2009 Aug 25. [Epub ahead of print]PMID: 19712767 [PubMed - as supplied by publisher]Related articles

    5.

    Formation of silicon-based molecular electronic structures using flip-chip lamination.

    Coll M, Miller LH, Richter LJ, Hines DR, Jurchescu OD, Gergel-Hackett N, Richter CA, Hacker CA.

    J Am Chem Soc. 2009 Sep 2;131(34):12451-7.PMID: 19670858 [PubMed - in process]Related articles

    6.

    Use of o-phthalaldehyde assay to determine protein contents of Alhydrogel-based vaccines.

    Zhu D, Saul A, Huang S, Martin LB, Miller LH, Rausch KM.

    Vaccine. 2009 Oct 9;27(43):6054-9. Epub 2009 Aug 4.PMID: 19660590 [PubMed - indexed for MEDLINE]Related articles

    7.

    Structure of the Plasmodium falciparum circumsporozoite protein, a leading malaria vaccine candidate.

    Plassmeyer ML, Reiter K, Shimp RL Jr, Kotova S, Smith PD, Hurt DE, House B, Zou X, Zhang Y, Hickman M, Uchime O, Herrera R, Nguyen V, Glen J, Lebowitz J, Jin AJ, Miller LH, MacDonald NJ, Wu Y, Narum DL.

    J Biol Chem. 2009 Sep 25;284(39):26951-63. Epub 2009 Jul 24.PMID: 19633296 [PubMed - indexed for MEDLINE]Related articles

    8.

    Molecular basis of binding of the Plasmodium falciparum receptor BAEBL to erythrocyte receptor glycophorin C.

    Jiang L, Duriseti S, Sun P, Miller LH.

    Mol Biochem Parasitol. 2009 Nov;168(1):49-54. Epub 2009 Jun 27.PMID: 19563830 [PubMed - indexed for MEDLINE]Related articles

    9.

    Anti-apical-membrane-antigen-1 antibody is more effective than anti-42-kilodalton-merozoite-surface-protein-1 antibody in inhibiting plasmodium falciparum growth, as determined by the in vitro growth inhibition assay.

    Miura K, Zhou H, Diouf A, Moretz SE, Fay MP, Miller LH, Martin LB, Pierce MA, Ellis RD, Mullen GE, Long CA.

    Clin Vaccine Immunol. 2009 Jul;16(7):963-8. Epub 2009 May 13.PMID: 19439523 [PubMed - indexed for MEDLINE]Related articles

    10.

    A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali.

    Sagara I, Dicko A, Ellis RD, Fay MP, Diawara SI, Assadou MH, Sissoko MS, Kone M, Diallo AI, Saye R, Guindo MA, Kante O, Niambele MB, Miura K, Mullen GE, Pierce M, Martin LB, Dolo A, Diallo DA, Doumbo OK, Miller LH, Saul A.

    Vaccine. 2009 May 18;27(23):3090-8. Epub 2009 Mar 25.PMID: 19428923 [PubMed - indexed for MEDLINE]Related articles

    11.

    A Phase 1 study of the blood-stage malaria vaccine candidate AMA1-C1/Alhydrogel with CPG 7909, using two different formulations and dosing intervals.

    Ellis RD, Mullen GE, Pierce M, Martin LB, Miura K, Fay MP, Long CA, Shaffer D, Saul A, Miller LH, Durbin AP.

    Vaccine. 2009 Jun 24;27(31):4104-9. Epub 2009 May 15.PMID: 19410624 [PubMed - indexed for MEDLINE]Related articles

    12.

    World Malaria Day 2009: what malaria knows about the immune system that immunologists still do not.

    Pierce SK, Miller LH.

    J Immunol. 2009 May 1;182(9):5171-7. Review.PMID: 19380759 [PubMed - indexed for MEDLINE]Related articles

    13.

    From tucson to genomics and transgenics: the vector biology network and the emergence of modern vector biology.

    Beaty BJ, Prager DJ, James AA, Jacobs-Lorena M, Miller LH, Law JH, Collins FH, Kafatos FC.

    PLoS Negl Trop Dis. 2009;3(3):e343. Epub 2009 Mar 31. No abstract available. PMID: 19333394 [PubMed - in process]Related articlesFree article

    14.

    Glycophorin B is the erythrocyte receptor of Plasmodium falciparum erythrocyte-binding ligand, EBL-1.

    Mayer DC, Cofie J, Jiang L, Hartl DL, Tracy E, Kabat J, Mendoza LH, Miller LH.

    Proc Natl Acad Sci U S A. 2009 Mar 31;106(13):5348-52. Epub 2009 Mar 11.PMID: 19279206 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals.

    Crompton PD, Mircetic M, Weiss G, Baughman A, Huang CY, Topham DJ, Treanor JJ, Sanz I, Lee FE, Durbin AP, Miura K, Narum DL, Ellis RD, Malkin E, Mullen GE, Miller LH, Martin LB, Pierce SK.

    J Immunol. 2009 Mar 1;182(5):3318-26.PMID: 19234231 [PubMed - indexed for MEDLINE]Related articles

    16.

    Structure of the DBL3x domain of pregnancy-associated malaria protein VAR2CSA complexed with chondroitin sulfate A.

    Singh K, Gittis AG, Nguyen P, Gowda DC, Miller LH, Garboczi DN.

    Nat Struct Mol Biol. 2008 Sep;15(9):932-8.PMID: 19172746 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Enhanced antibody responses to Plasmodium falciparum Pfs28 induced in mice by conjugation to ExoProtein A of Pseudomonas aeruginosa with an improved procedure.

    Qian F, Aebig JA, Reiter K, Barnafo E, Zhang Y, Shimp RL Jr, Rausch KM, Jones DS, Zhu D, Lambert L, Mullen GE, Narum DL, Miller LH, Wu Y.

    Microbes Infect. 2009 Mar;11(3):408-12. Epub 2008 Dec 27.PMID: 19146977 [PubMed - indexed for MEDLINE]Related articles

    18.

    Characterization of a protective Escherichia coli-expressed Plasmodium falciparum merozoite surface protein 3 indicates a non-linear, multi-domain structure.

    Tsai CW, Duggan PF, Jin AJ, Macdonald NJ, Kotova S, Lebowitz J, Hurt DE, Shimp RL Jr, Lambert L, Miller LH, Long CA, Saul A, Narum DL.

    Mol Biochem Parasitol. 2009 Mar;164(1):45-56. Epub 2008 Nov 27.PMID: 19073223 [PubMed - indexed for MEDLINE]Related articles

    19.

    Comparison of biological activity of human anti-apical membrane antigen-1 antibodies induced by natural infection and vaccination.

    Miura K, Zhou H, Moretz SE, Diouf A, Thera MA, Dolo A, Doumbo O, Malkin E, Diemert D, Miller LH, Mullen GE, Long CA.

    J Immunol. 2008 Dec 15;181(12):8776-83.PMID: 19050299 [PubMed - indexed for MEDLINE]Related articles

    20.

    The cysteine-rich interdomain region from the highly variable plasmodium falciparum erythrocyte membrane protein-1 exhibits a conserved structure.

    Klein MM, Gittis AG, Su HP, Makobongo MO, Moore JM, Singh S, Miller LH, Garboczi DN.

    PLoS Pathog. 2008 Sep 5;4(9):e1000147.PMID: 18773118 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Sickle cell trait is associated with a delayed onset of malaria: implications for time-to-event analysis in clinical studies of malaria.

    Crompton PD, Traore B, Kayentao K, Doumbo S, Ongoiba A, Diakite SA, Krause MA, Doumtabe D, Kone Y, Weiss G, Huang CY, Doumbia S, Guindo A, Fairhurst RM, Miller LH, Pierce SK, Doumbo OK.

    J Infect Dis. 2008 Nov 1;198(9):1265-75.PMID: 18752444 [PubMed - indexed for MEDLINE]Related articlesFree article

    22.

    Phase 1 trial of AMA1-C1/Alhydrogel plus CPG 7909: an asexual blood-stage vaccine for Plasmodium falciparum malaria.

    Mullen GE, Ellis RD, Miura K, Malkin E, Nolan C, Hay M, Fay MP, Saul A, Zhu D, Rausch K, Moretz S, Zhou H, Long CA, Miller LH, Treanor J.

    PLoS One. 2008 Aug 13;3(8):e2940.PMID: 18698359 [PubMed - indexed for MEDLINE]Related articlesFree article

    23.

    Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion.

    Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, Nawaz F, Mu J, Jiang L, Miller LH, Wellems TE.

    Cell Host Microbe. 2008 Jul 17;4(1):40-51.PMID: 18621009 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Phase 1 trial of malaria transmission blocking vaccine candidates Pfs25 and Pvs25 formulated with montanide ISA 51.

    Wu Y, Ellis RD, Shaffer D, Fontes E, Malkin EM, Mahanty S, Fay MP, Narum D, Rausch K, Miles AP, Aebig J, Orcutt A, Muratova O, Song G, Lambert L, Zhu D, Miura K, Long C, Saul A, Miller LH, Durbin AP.

    PLoS One. 2008 Jul 9;3(7):e2636.PMID: 18612426 [PubMed - indexed for MEDLINE]Related articlesFree article

    25.

    How does cot death prevention advice influence parents' behaviour?

    Miller LH, Fraser A, Moy R.

    Child Care Health Dev. 2008 Sep;34(5):613-8. Epub 2008 Jun 28.PMID: 18549437 [PubMed - indexed for MEDLINE]Related articles

    26.

    Addition of CpG ODN to recombinant Pseudomonas aeruginosa ExoProtein A conjugates of AMA1 and Pfs25 greatly increases the number of responders.

    Qian F, Rausch KM, Muratova O, Zhou H, Song G, Diouf A, Lambert L, Narum DL, Wu Y, Saul A, Miller LH, Long CA, Mullen GE.

    Vaccine. 2008 May 12;26(20):2521-7. Epub 2008 Mar 27.PMID: 18423804 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Phase 1 study of a combination AMA1 blood stage malaria vaccine in Malian children.

    Dicko A, Sagara I, Ellis RD, Miura K, Guindo O, Kamate B, Sogoba M, Niambelé MB, Sissoko M, Baby M, Dolo A, Mullen GE, Fay MP, Pierce M, Diallo DA, Saul A, Miller LH, Doumbo OK.

    PLoS One. 2008 Feb 13;3(2):e1563.PMID: 18270560 [PubMed - indexed for MEDLINE]Related articlesFree article

    28.

    Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteers.

    Huaman MC, Martin LB, Malkin E, Narum DL, Miller LH, Mahanty S, Long CA.

    J Immunol. 2008 Feb 1;180(3):1451-61.PMID: 18209040 [PubMed - indexed for MEDLINE]Related articlesFree article

    29.

    Year-to-year variation in the age-specific incidence of clinical malaria in two potential vaccine testing sites in Mali with different levels of malaria transmission intensity.

    Dicko A, Sagara I, Diemert D, Sogoba M, Niambele MB, Dao A, Dolo G, Yalcouye D, Diallo DA, Saul A, Miller LH, Toure YT, Klion AD, Doumbo OK.

    Am J Trop Med Hyg. 2007 Dec;77(6):1028-33.PMID: 18165516 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    Development and characterization of a standardized ELISA including a reference serum on each plate to detect antibodies induced by experimental malaria vaccines.

    Miura K, Orcutt AC, Muratova OV, Miller LH, Saul A, Long CA.

    Vaccine. 2008 Jan 10;26(2):193-200. Epub 2007 Nov 20.PMID: 18054414 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Mononeme: a new secretory organelle in Plasmodium falciparum merozoites identified by localization of rhomboid-1 protease.

    Singh S, Plassmeyer M, Gaur D, Miller LH.

    Proc Natl Acad Sci U S A. 2007 Dec 11;104(50):20043-8. Epub 2007 Nov 28.PMID: 18048320 [PubMed - indexed for MEDLINE]Related articlesFree article

    32.

    Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion.

    Gaur D, Singh S, Singh S, Jiang L, Diouf A, Miller LH.

    Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17789-94. Epub 2007 Oct 30.PMID: 17971435 [PubMed - indexed for MEDLINE]Related articlesFree article

    33.

    Impact of a Plasmodium falciparum AMA1 vaccine on antibody responses in adult Malians.

    Dicko A, Diemert DJ, Sagara I, Sogoba M, Niambele MB, Assadou MH, Guindo O, Kamate B, Baby M, Sissoko M, Malkin EM, Fay MP, Thera MA, Miura K, Dolo A, Diallo DA, Mullen GE, Long CA, Saul A, Doumbo O, Miller LH.

    PLoS One. 2007 Oct 17;2(10):e1045.PMID: 17940609 [PubMed - indexed for MEDLINE]Related articlesFree article

    34.

    In immunization with Plasmodium falciparum apical membrane antigen 1, the specificity of antibodies depends on the species immunized.

    Miura K, Zhou H, Muratova OV, Orcutt AC, Giersing B, Miller LH, Long CA.

    Infect Immun. 2007 Dec;75(12):5827-36. Epub 2007 Oct 8.PMID: 17923516 [PubMed - indexed for MEDLINE]Related articlesFree article

    35.

    Conjugating recombinant proteins to Pseudomonas aeruginosa ExoProtein A: a strategy for enhancing immunogenicity of malaria vaccine candidates.

    Qian F, Wu Y, Muratova O, Zhou H, Dobrescu G, Duggan P, Lynn L, Song G, Zhang Y, Reiter K, MacDonald N, Narum DL, Long CA, Miller LH, Saul A, Mullen GE.

    Vaccine. 2007 May 16;25(20):3923-33. Epub 2007 Mar 13.PMID: 17428587 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    Phase 1 study of two merozoite surface protein 1 (MSP1(42)) vaccines for Plasmodium falciparum malaria.

    Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB.

    PLoS Clin Trials. 2007;2(4):e12. Epub 2007 Apr 6.PMID: 17415408 [PubMed]Related articlesFree article

    37.

    Long-lasting and transmission-blocking activity of antibodies to Plasmodium falciparum elicited in mice by protein conjugates of Pfs25.

    Kubler-Kielb J, Majadly F, Wu Y, Narum DL, Guo C, Miller LH, Shiloach J, Robbins JB, Schneerson R.

    Proc Natl Acad Sci U S A. 2007 Jan 2;104(1):293-8. Epub 2006 Dec 26.PMID: 17190797 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Sustained high-titer antibody responses induced by conjugating a malarial vaccine candidate to outer-membrane protein complex.

    Wu Y, Przysiecki C, Flanagan E, Bello-Irizarry SN, Ionescu R, Muratova O, Dobrescu G, Lambert L, Keister D, Rippeon Y, Long CA, Shi L, Caulfield M, Shaw A, Saul A, Shiver J, Miller LH.

    Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18243-8. Epub 2006 Nov 16.PMID: 17110440 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Reply.

    Rowe JA, Newbold CI, Moulds JM, Miller LH.

    Parasitol Today. 1998 Dec;14(6):250. No abstract available. PMID: 17040770 [PubMed - in process]Related articles

    40.

    Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.

    Singh S, Miura K, Zhou H, Muratova O, Keegan B, Miles A, Martin LB, Saul AJ, Miller LH, Long CA.

    Infect Immun. 2006 Aug;74(8):4573-80.PMID: 16861644 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    The glycophorin C N-linked glycan is a critical component of the ligand for the Plasmodium falciparum erythrocyte receptor BAEBL.

    Mayer DC, Jiang L, Achur RN, Kakizaki I, Gowda DC, Miller LH.

    Proc Natl Acad Sci U S A. 2006 Feb 14;103(7):2358-62. Epub 2006 Feb 6.PMID: 16461900 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Immunization of Aotus monkeys with recombinant cysteine-rich interdomain region 1 alpha protects against severe disease during Plasmodium falciparum reinfection.

    Makobongo MO, Keegan B, Long CA, Miller LH.

    J Infect Dis. 2006 Mar 1;193(5):731-40. Epub 2006 Jan 30.PMID: 16453270 [PubMed - indexed for MEDLINE]Related articles

    43.

    Plasmodium vivax: transmission-blocking immunity in a malaria-endemic area of Colombia.

    Arévalo-Herrera M, Solarte Y, Zamora F, Mendez F, Yasnot MF, Rocha L, Long C, Miller LH, Herrera S.

    Am J Trop Med Hyg. 2005 Nov;73(5 Suppl):38-43.PMID: 16291765 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Upregulation of expression of the reticulocyte homology gene 4 in the Plasmodium falciparum clone Dd2 is associated with a switch in the erythrocyte invasion pathway.

    Gaur D, Furuya T, Mu J, Jiang LB, Su XZ, Miller LH.

    Mol Biochem Parasitol. 2006 Feb;145(2):205-15. Epub 2005 Oct 25.PMID: 16289357 [PubMed - indexed for MEDLINE]Related articles

    45.

    Overproduction of Pichia pastoris or Plasmodium falciparum protein disulfide isomerase affects expression, folding and O-linked glycosylation of a malaria vaccine candidate expressed in P. pastoris.

    Tsai CW, Duggan PF, Shimp RL Jr, Miller LH, Narum DL.

    J Biotechnol. 2006 Feb 24;121(4):458-70. Epub 2005 Nov 7.PMID: 16274825 [PubMed - indexed for MEDLINE]Related articles

    46.

    A comparison of three techniques to obtain root coverage on mandibular incisors.

    Harris RJ, Miller LH, Harris CR, Miller RJ.

    J Periodontol. 2005 Oct;76(10):1758-67.PMID: 16253099 [PubMed - indexed for MEDLINE]Related articles

    47.

    Complications with surgical procedures utilizing connective tissue grafts: a follow-up of 500 consecutively treated cases.

    Harris RJ, Miller R, Miller LH, Harris C.

    Int J Periodontics Restorative Dent. 2005 Oct;25(5):449-59.PMID: 16250567 [PubMed - indexed for MEDLINE]Related articles

    48.

    Revisiting Freund's incomplete adjuvant for vaccines in the developing world.

    Miller LH, Saul A, Mahanty S.

    Trends Parasitol. 2005 Sep;21(9):412-4. Review.PMID: 16043410 [PubMed - indexed for MEDLINE]Related articles

    49.

    posttranslational modification of recombinant Plasmodium falciparum apical membrane antigen 1: impact on functional immune responses to a malaria vaccine candidate.

    Giersing B, Miura K, Shimp R, Wang J, Zhou H, Orcutt A, Stowers A, Saul A, Miller LH, Long C, Singh S.

    Infect Immun. 2005 Jul;73(7):3963-70.PMID: 15972483 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Massage therapy versus traditional therapy for low back pain relief: implications for holistic nursing practice.

    Melancon B, Miller LH.

    Holist Nurs Pract. 2005 May-Jun;19(3):116-21.PMID: 15923937 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...